Surgery recovery guidelines for high-risk cancer patients
Part of Cancer clinical trials.
This trial asks surgeons who do abdominal cancer surgery to help create better recovery guidelines after high-risk operations. It aims to improve how well patients function after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a surgeon who does abdominal surgery for cancer.
- You work at the University of Alabama at Birmingham.
- You are willing to help develop postoperative recovery guidelines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a “risk-based plan” to help guide care after major cancer surgery, aiming to improve recovery and outcomes. You may be in the study when you’re about to have elective (planned) high-risk cancer surgery and then again just before hospital discharge.
This study compares different ways to rebuild the pelvic, perineal, or abdominal area after surgery for cancer or chronic inflammation. It aims to find which method works best for patients like you.
This trial studies a new way to help patients recover after surgery. If you are an adult having any type of operation, you may be able to take part.
This trial tests a program to help women recover faster after surgery for cervical, uterine, or ovarian cancer. It focuses on improving recovery steps to reduce hospital stay and make the process smoother.
This trial studies a “prehabilitation” program—exercise and coaching before surgery—to help frail older adults recover better after major digestive cancer surgery. It may help you strengthen your body and function before the operation, which can improve outcomes after surgery.
This study looks at how older adults (65+) with digestive tract cancers respond to surgery aimed at a cure. Researchers want to see what factors affect recovery and quality of life after the operation.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.